No abstract available
Publication types
-
Comment
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / pharmacokinetics*
-
Benzamides
-
Cytogenetic Analysis
-
Drug Monitoring
-
Female
-
Fusion Proteins, bcr-abl / analysis
-
Humans
-
Imatinib Mesylate
-
In Situ Hybridization, Fluorescence
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myeloid, Accelerated Phase
-
Leukemia, Myeloid, Chronic-Phase
-
Male
-
Middle Aged
-
Piperazines / administration & dosage*
-
Piperazines / pharmacokinetics*
-
Polymerase Chain Reaction
-
Pyrimidines / administration & dosage*
-
Pyrimidines / pharmacokinetics*
-
Risk Assessment
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl